← SynDRA
ERCALCITRIOL
SynDRA canonical compound SYN0039860 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | VDR |
| Mechanism of action | vitamin D receptor agonist |
All known targets
Mechanisms of action (all sources)
- vitamin D receptor agonist
Cross-references
Synonyms
- 1,25-dihydroxycalciferol
- 1,25-dihydroxyergocalciferol
- 1,25-dihydroxyvitamin d2
- 1.alpha.,25-dihydroxyvitamin d2
- RO-17-6218
- 1,25-Dihydroxycalciferol
- 1alpha,25-Dihydroxyvitamin D2
- 1,25-Dihydroxyergocalciferol
- 1,25-Dihydroxyvitamin D2
- 1alpha,25-Dihydroxycalciferol
- 1alpha,25-dihydroxyergocalciferol
- Ro 17-6218
- 1a,25-Dihydroxyvitamin D2
- 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,25-triol,(1a,3b,5Z,7E,22E)-
- 5RWP08OQ36
- (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- 1,3-Cyclohexanediol, 4-methylene-5-((2E)-2-((1R,3aS,7aR)-octahydro-1-((1R,2E)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl)-7a-methyl-4H-inden-4-ylidene)ethylidene)-, (1R,3S,5Z)-
- 1alpha,25-dihydroxyvitamin D2 / 1alpha,,25-dihydroxyergocalciferol
- (5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3,25-triol
- UNII-5RWP08OQ36
- 1-alpha,25-Dihydroxy vitamin d2
- MFCD00869499
- 1a,25-Dihydroxycalciferol
- 25-Hydroxy Doxercalciferol
- 1,25-Dihydroxy vitamin D
- 1,25-dihydroxy Vitamin D2
- 1?,25-Dihydroxyvitamin D2
- 1a,25-Dihydroxyergocalciferol
- SCHEMBL264875
- CHEMBL4303615
- CHEBI:86320
- 1-alpha,25-Dihydroxyvitamin D2
- DTXSID90429509
- 1 alpha ,25-Dihydroxyvitamin D2
- EX-A4431
- LMST03010040
- AKOS024457904
- ZINC100163363
- CS-0394
Look up ERCALCITRIOL in the interactive SynDRA portal →